Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats

Narumi Hashikawa-Hobara, Naoya Hashikawa, Yusuke Inoue, Hitomi Sanda, Yoshito Zamami, Shingo Takatori, Hiromu Kawasaki

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We have shown previously that stimulation of the angiotensin II type 2 receptor (AT 2R) results in nerve facilitation. In this study, we determined the capacity of candesartan to correct expression patterns characteristic of neuropathy and AT 2R-mediated neurite outgrowth in the fructose-induced insulin-resistant rat, which is one of the human hyperinsulinemia models. Wistar rats received a 15% (w/v) fructose solution in their drinking water for 4 weeks (fructose-drinking rats [FDRs]), with or without candesartan (5 mg/kg/day). We evaluated physiological and behavioral parameters and performed immunohistochemical studies. We found that the FDR developed insulin resistance and downregulated both AT 2R neuronal function and phosphorylated Akt expression in dorsal root ganglia (DRG) neurons. Candesartan improved neurite outgrowth in the FDR, which was associated with the restoration of AT 2R and phosphorylated Akt expression. Furthermore, downregulation of phosphoinositide 3-kinase (PI3K) inhibited AT 2R-mediated neurite outgrowth in control DRG cells. PI3K activation increased AT 2R-mediated neurite outgrowth and phosphorylated Akt expression in FDR DRG cells. These results suggest that the decrease of AT 2R-mediated neurite outgrowth in FDRs is likely to be the result of decreased PI3K-dependent Akt activation. Candesartan improved AT 2R neuronal function and Akt phosphorylation, which were associated with sensory nerve defects and insulin sensitivity in the FDR.

Original languageEnglish
Pages (from-to)925-932
Number of pages8
JournalDiabetes
Volume61
Issue number4
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Angiotensin Type 2 Receptor
1-Phosphatidylinositol 4-Kinase
Fructose
Insulin
Drinking
Spinal Ganglia
Insulin Resistance
Down-Regulation
Neuronal Outgrowth
candesartan cilexetil
Hyperinsulinism
Drinking Water
Wistar Rats
Phosphorylation
Neurons
candesartan

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. / Hashikawa-Hobara, Narumi; Hashikawa, Naoya; Inoue, Yusuke; Sanda, Hitomi; Zamami, Yoshito; Takatori, Shingo; Kawasaki, Hiromu.

In: Diabetes, Vol. 61, No. 4, 04.2012, p. 925-932.

Research output: Contribution to journalArticle

Hashikawa-Hobara, N, Hashikawa, N, Inoue, Y, Sanda, H, Zamami, Y, Takatori, S & Kawasaki, H 2012, 'Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats', Diabetes, vol. 61, no. 4, pp. 925-932. https://doi.org/10.2337/db11-1468
Hashikawa-Hobara, Narumi ; Hashikawa, Naoya ; Inoue, Yusuke ; Sanda, Hitomi ; Zamami, Yoshito ; Takatori, Shingo ; Kawasaki, Hiromu. / Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. In: Diabetes. 2012 ; Vol. 61, No. 4. pp. 925-932.
@article{04277d22f38a4938a2681ce2279ed770,
title = "Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats",
abstract = "We have shown previously that stimulation of the angiotensin II type 2 receptor (AT 2R) results in nerve facilitation. In this study, we determined the capacity of candesartan to correct expression patterns characteristic of neuropathy and AT 2R-mediated neurite outgrowth in the fructose-induced insulin-resistant rat, which is one of the human hyperinsulinemia models. Wistar rats received a 15{\%} (w/v) fructose solution in their drinking water for 4 weeks (fructose-drinking rats [FDRs]), with or without candesartan (5 mg/kg/day). We evaluated physiological and behavioral parameters and performed immunohistochemical studies. We found that the FDR developed insulin resistance and downregulated both AT 2R neuronal function and phosphorylated Akt expression in dorsal root ganglia (DRG) neurons. Candesartan improved neurite outgrowth in the FDR, which was associated with the restoration of AT 2R and phosphorylated Akt expression. Furthermore, downregulation of phosphoinositide 3-kinase (PI3K) inhibited AT 2R-mediated neurite outgrowth in control DRG cells. PI3K activation increased AT 2R-mediated neurite outgrowth and phosphorylated Akt expression in FDR DRG cells. These results suggest that the decrease of AT 2R-mediated neurite outgrowth in FDRs is likely to be the result of decreased PI3K-dependent Akt activation. Candesartan improved AT 2R neuronal function and Akt phosphorylation, which were associated with sensory nerve defects and insulin sensitivity in the FDR.",
author = "Narumi Hashikawa-Hobara and Naoya Hashikawa and Yusuke Inoue and Hitomi Sanda and Yoshito Zamami and Shingo Takatori and Hiromu Kawasaki",
year = "2012",
month = "4",
doi = "10.2337/db11-1468",
language = "English",
volume = "61",
pages = "925--932",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats

AU - Hashikawa-Hobara, Narumi

AU - Hashikawa, Naoya

AU - Inoue, Yusuke

AU - Sanda, Hitomi

AU - Zamami, Yoshito

AU - Takatori, Shingo

AU - Kawasaki, Hiromu

PY - 2012/4

Y1 - 2012/4

N2 - We have shown previously that stimulation of the angiotensin II type 2 receptor (AT 2R) results in nerve facilitation. In this study, we determined the capacity of candesartan to correct expression patterns characteristic of neuropathy and AT 2R-mediated neurite outgrowth in the fructose-induced insulin-resistant rat, which is one of the human hyperinsulinemia models. Wistar rats received a 15% (w/v) fructose solution in their drinking water for 4 weeks (fructose-drinking rats [FDRs]), with or without candesartan (5 mg/kg/day). We evaluated physiological and behavioral parameters and performed immunohistochemical studies. We found that the FDR developed insulin resistance and downregulated both AT 2R neuronal function and phosphorylated Akt expression in dorsal root ganglia (DRG) neurons. Candesartan improved neurite outgrowth in the FDR, which was associated with the restoration of AT 2R and phosphorylated Akt expression. Furthermore, downregulation of phosphoinositide 3-kinase (PI3K) inhibited AT 2R-mediated neurite outgrowth in control DRG cells. PI3K activation increased AT 2R-mediated neurite outgrowth and phosphorylated Akt expression in FDR DRG cells. These results suggest that the decrease of AT 2R-mediated neurite outgrowth in FDRs is likely to be the result of decreased PI3K-dependent Akt activation. Candesartan improved AT 2R neuronal function and Akt phosphorylation, which were associated with sensory nerve defects and insulin sensitivity in the FDR.

AB - We have shown previously that stimulation of the angiotensin II type 2 receptor (AT 2R) results in nerve facilitation. In this study, we determined the capacity of candesartan to correct expression patterns characteristic of neuropathy and AT 2R-mediated neurite outgrowth in the fructose-induced insulin-resistant rat, which is one of the human hyperinsulinemia models. Wistar rats received a 15% (w/v) fructose solution in their drinking water for 4 weeks (fructose-drinking rats [FDRs]), with or without candesartan (5 mg/kg/day). We evaluated physiological and behavioral parameters and performed immunohistochemical studies. We found that the FDR developed insulin resistance and downregulated both AT 2R neuronal function and phosphorylated Akt expression in dorsal root ganglia (DRG) neurons. Candesartan improved neurite outgrowth in the FDR, which was associated with the restoration of AT 2R and phosphorylated Akt expression. Furthermore, downregulation of phosphoinositide 3-kinase (PI3K) inhibited AT 2R-mediated neurite outgrowth in control DRG cells. PI3K activation increased AT 2R-mediated neurite outgrowth and phosphorylated Akt expression in FDR DRG cells. These results suggest that the decrease of AT 2R-mediated neurite outgrowth in FDRs is likely to be the result of decreased PI3K-dependent Akt activation. Candesartan improved AT 2R neuronal function and Akt phosphorylation, which were associated with sensory nerve defects and insulin sensitivity in the FDR.

UR - http://www.scopus.com/inward/record.url?scp=84859529833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859529833&partnerID=8YFLogxK

U2 - 10.2337/db11-1468

DO - 10.2337/db11-1468

M3 - Article

VL - 61

SP - 925

EP - 932

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -